A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease Article

sustainable development goals

publication date

  • September 1, 2019

webpage

published in

start page

  • 1230

end page

  • 1237

volume

  • 126

issue

  • 9